@FiercePharma: Novartis faces new obstacle in Alcon deal. Article | Follow @FiercePharma
> Drugmakers shopping for a Japanese partner, take note: Sawai Pharmaceutical, Japan's No.1 generics maker, says it will need to consider a capital tie-up with a bigger drugmaker in the future. Report
> U.S. health regulators have cautioned Australia's CSL after uncovering problems at its influenza vaccine manufacturing plant and want to meet with company officials. Report
> Israeli drugmaker Teva Pharmaceutical says it won FDA approval for a generic version of Wyeth's antidepressant drug Effexor XR. Report
> AstraZeneca Pharma India said it has received a delisting offer from 90 percent-owner AstraZeneca Pharmaceuticals AB, sending its shares higher. Report
> Teva Pharmaceutical Industries won the green light from FDA to sell its generic version of AstraZeneca's cancer blockbuster Arimidex. Report
> Indian drugmaker Dr. Reddy's Laboratories said it has launched a copycat version of AstraZeneca's breast cancer drug Arimidex in the U.S. Report
> Perrigo acquired exclusive U.S. store brand rights for over-the-counter versions of the Sanofi-Aventis allergy drugs Allegra and Allegra D-12. Release
Biotech News
@FierceBiotech: Pharma pipelines mired by poor productivity, shrinking R&D budgets. Article | Follow @FierceBiotech
@JohnCFierce: IBM says that cloud computing can help reduce the 8-12% of trial costs related to data juggling. Article | @JohnCFierce
> Sanofi plans 'industrial scale' PhIII program for dengue vaccine. Item
> Forest pain drug fails to beat out a placebo in PhII. Report
> Bind banks $12.4M round as lead program heads into PhI. News
Biotech Research News
> Harvard, Yale researchers make strides in lung regeneration. Article
> French adopt new approach to biomedical research. Item
> NIH research budget to shrivel as Obama demands discipline. Report
> Developers lobby for new federal R&D incentives for rare diseases. News
> ViaCyte wins kudos for ESC program to treat diabetes. Story
> Nanotubes used to detect proteins. Article
Pharma Manufacturing News
> J&J expects plant fixes to take all year. News
> Dendreon scrambles to boost Provenge production. Report
> New markets for pharma bring supply-chain worries. Item
> ViroPharma aims to double manufacturing capacity. Story
> Contract manufacturing to see double-digit growth. News
And Finally... Could public transit be the answer to the obesity epidemic? Report